Search

everythinglearnresearchcommunity

for

Search:↓

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Yellow dots are common in severe alopecia areata.

Pediatric alopecia areata needs better treatments and psychological support.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Alopecia areata treatment varies, with no optimal method established yet.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Adolescents with severe alopecia incur significantly higher healthcare costs.